Literature DB >> 19773142

Characterization of metabolites of worenine in rat biological samples using liquid chromatography-tandem mass spectrometry.

Huaixia Chen1, Jianlin Huang, Juan Li.   

Abstract

The in vivo and in vitro metabolites of worenine in rat were identified or characterized using a specific and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. In vivo samples including rat urine, feces, and plasma samples were collected after ingestion of 25 mg/kg worenine to healthy rats. The in vivo and in vitro samples were cleaned up by a solid-phase extraction procedure (C18 cartridges) and a liquid-liquid extraction procedure, respectively. Then these pretreated samples were injected into a reversed-phase C18 column with mobile phase of methanol-ammonium acetate (2mM, adjusted to pH 3.5 with formic acid) (60:40, v/v) and detected by an on-line MS/MS system. As a result, at least twenty-seven metabolites and the parent medicine were found in rat urine after ingestion of worenine. Seven metabolites and the parent medicine were identified or characterized in rat feces. Three metabolites and the parent medicine were detected in rat plasma. One metabolite was found in the rat intestinal flora incubation mixture, and three metabolites were characterized in the homogenized liver incubation mixture. The main phase I metabolism of worenine in rat was dehydrogenization, hydrogenation, hydroxylation, and demethylene reactions, and that of phase II was sulfation and glucuronidation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773142     DOI: 10.1016/j.jpba.2009.08.026

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Worenine Prevents Solar Ultraviolet-Induced Sunburn by Inhibiting JNK2.

Authors:  Juanjuan Xiao; Hui Lu; Tengfei Ma; Xiaofang Ni; Teding Chang; Man Liu; Nijie Li; Peijiang Lu; Changshu Ke; Qin Tian; Ling Zou; Fei Wang; Wei Wang; Lu Zhang; Ping Yuan; Lin Liu; Jianmin Zhang; Fei Shi; Qiuhong Duan; Feng Zhu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.